4 December 2015
Have you experienced depression only after the age of 55?
We are looking for volunteers to assist with a new study and if you fit the criteria we'd like to hear from you.
The purpose of this study, organised by the department of clinical neurosciences, is to look into neural pathways in the brain of older people with depression, helping us to better understand the causes of late onset depression. The study will contribute to more effective treatments in the future.
If you would like to take part you will be asked to attend the hospital for a day. The study day will involve some questionnaires and you will be asked about your medical history, family history, physical health and emotional wellbeing. There will be a physical and neurological examination and you will also be asked to have two brain scans; a DaT SPECT scan, which looks at the neural pathways of dopamine in the brain, and an MRI.
If you are interested in taking part or would like to find out more please contact Hiba Kazmi on 07984499967 or email email@example.com.
By contacting us to discuss the study you are in no way committing yourself to participate and can hear about what the research involves and whether it is something you would like to be involved with.
Lunch and travel expenses will be reimbursed.
Image: DaT SPECT scan showing neural pathways of dopamine in the brain.
Notes to editors
For more information, please contact firstname.lastname@example.org.
About the Royal Free London NHS Foundation Trust
The Royal Free began as a pioneering organisation and continues to play a leading role in the care of patients. Our mission is to provide world class expertise and local care. In the 21st century, the Royal Free London continues to lead improvements in healthcare.
The Royal Free London attracts patients from across the country and beyond to its specialist services in liver, kidney and bone marrow transplantation, haemophilia, renal, HIV, infectious diseases, plastic surgery, immunology, vascular surgery, cardiology, amyloidosis and scleroderma and we are a member of the academic health science partnership UCLPartners.